ATRI: Atrion Corporation Inc. Projected Price to Earnings

Brandmark of Atrion Corporation (ATRI)

Scalability in the production of specialized medical devices through stamping automation reduces costs, which is supported by the company's forward P/E ratio. Business revenues rely on the supply of cardio and ophthalmic surgical instruments, while the implementation of AI-driven quality control optimizes assembly. Within this trend, the 0.00 level serves as a critical benchmark determining the investment attractiveness and the ability of Atrion Corporation (ATRI) to generate cash flow.

ATRI - Atrion Market Cap to Projected Earnings over the range 07/04/2022 - 08/31/2024

Analytical breakdowns and data insights for company Atrion (ATRI)

- stock value and consensus price forecast:
Summary company analysis:ATRI Atrion Corp
Signature product of atrioncorp.com

For Atrion Corporation (ATRI), the change in the company's forward P/E reflects the market's valuation of the potential for high-margin cardiology and oncology components amidst technological competition. This metric is calculated as the ratio of the current share price to the projected earnings per share, allowing investors to determine the extent of the premium paid for future growth and assess the business model's resilience to market cycles.

Direct competitors

Future Price to Earnings Intuitive Surgical Inc (ISRG)|DHR (Danaher Corp) - Future Price to Earnings Multiple|Forward P/E Multiple BDX (bd.com)|Market Cap to Projected Earnings steris.com (STE)|WST - Future Price to Earnings|BAX (Baxter International Inc.) - Price to Future Earnings Ratio|Masimo Corporation (MASI) - Future Price to Earnings|Price to Future Earnings Ratio STVN|Projected Price to Earnings TFX|Merit Medical (MMSI) - Market Cap to Projected Earnings|Projected Price to Earnings NVST (Envista Holdings)|Market Cap to Future Earnings Ratio ICUI|Future Price to Earnings Dentsply XRAY|Future Price to Earnings Multiple LMAT|ATRC: Projected Price to Earnings|STAA - Forward P/E Multiple|ChromaDex Corp (NAGE) - Future Price to Earnings|Projected Price to Earnings ZimVie|ANGO (angiodynamics.com) - Forward P/E Multiple|Projected Price to Earnings Ratio Cerus Inc CERS|Future Price to Earnings Teknova (TKNO)|Monogram Orthopedics - Price to Future Earnings Ratio|Sharps Technology - Projected Price to Earnings|Market Cap to Future Earnings Ratio INFU (InfuSystem Holdings)|UTMD - Future Price to Earnings|Market Cap to Projected Earnings KORU Medical KRMD|Nyxoah (NYXH) - Future Price to Earnings|Projected Price to Earnings Microbot Medical Inc.|Future Price to Earnings Pro-Dex|Projected Price to Earnings Ratio Zentek Ltd ZTEK|Projected Price to Earnings ELUT (Elutia Inc)|Future Price to Earnings MLSS (Milestone Scientific Corp)|Forward P/E Multiple NXGL (NEXGEL Inc)|Forward P/E Multiple Retractable Tech RVP|Harvard Bioscience Inc. - Forward P/E Multiple|Market Cap to Projected Earnings Femasys Corp FEMY|MHUA: Forward P/E Multiple|Projected Price to Earnings Predictive Oncology|Projected Price to Earnings CJMB|Projected Price to Earnings Ratio NeuroMetrix NURO